Get startedLog in
    Picture of Nang Kuang Pharmaceutical Co logo

    1752 — Nang Kuang Pharmaceutical Co Cashflow Statement

    0.000.00%
    tw flag iconLast trade - 00:00
    HealthcareBalancedSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Nang Kuang Pharmaceutical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line235411214303291
    Depreciation
    Amortisation
    Non-Cash Items26.9-75.914223.431.3
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital115-142-195-43.1-41.5
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities557369343466464
    Capital Expenditures-160-94.2-301-526-281
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-132-15.7-28.8154-0.891
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-291-110-330-372-282
    Financing Cash Flow Items030.30.056-0.2686.11
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-114-275-35.8-171-138
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash151-15.9-22.7-76.944.1